Oncopeptides AB (publ) (STO:ONCO)
Sweden
· Delayed Price · Currency is SEK 1.576
-0.006 (-0.38%)
Mar 9, 2026, 5:29 PM CET
Oncopeptides AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -249.59 | -284.61 | -249.11 | -337.95 | -1,430 | Upgrade
|
| Depreciation & Amortization | - | 9.75 | 11.04 | 16.84 | 14.57 | Upgrade
|
| Other Amortization | - | - | - | 0.32 | 0.42 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 16.59 | Upgrade
|
| Stock-Based Compensation | - | 10.91 | 11.5 | 14.81 | 14.54 | Upgrade
|
| Other Operating Activities | 12.72 | 6.06 | 4.14 | -3.84 | -94.11 | Upgrade
|
| Change in Accounts Receivable | - | -4.3 | -16.02 | 53.17 | 24.66 | Upgrade
|
| Change in Inventory | - | -1.95 | -2.42 | -1.46 | -0.32 | Upgrade
|
| Change in Accounts Payable | - | 3.15 | -13.19 | -22.89 | -104.91 | Upgrade
|
| Change in Other Net Operating Assets | 20.37 | 0.42 | -25.42 | -139.52 | 42.49 | Upgrade
|
| Operating Cash Flow | -216.49 | -260.57 | -279.49 | -420.51 | -1,516 | Upgrade
|
| Capital Expenditures | - | -0.36 | -0.12 | -2.51 | -0.34 | Upgrade
|
| Investment in Securities | - | 0.85 | -0 | - | - | Upgrade
|
| Other Investing Activities | - | 0 | 0 | - | - | Upgrade
|
| Investing Cash Flow | - | 0.5 | -0.12 | -2.51 | -0.34 | Upgrade
|
| Long-Term Debt Repaid | - | -8.03 | -9.14 | -15.54 | -15.41 | Upgrade
|
| Net Debt Issued (Repaid) | - | -8.03 | -9.14 | -15.54 | -15.41 | Upgrade
|
| Issuance of Common Stock | - | 313.48 | 116.02 | 436.02 | 1,116 | Upgrade
|
| Other Financing Activities | 122.16 | -41.64 | - | -28.07 | -67.05 | Upgrade
|
| Financing Cash Flow | 122.16 | 263.81 | 106.89 | 392.4 | 1,034 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.95 | 1.39 | 1.61 | 12.94 | 4.63 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -0 | - | -0 | Upgrade
|
| Net Cash Flow | -96.28 | 5.13 | -171.11 | -17.67 | -478.07 | Upgrade
|
| Free Cash Flow | -216.49 | -260.93 | -279.61 | -423.02 | -1,517 | Upgrade
|
| Free Cash Flow Margin | -304.41% | -824.47% | -793.89% | -5063.03% | -1282.16% | Upgrade
|
| Free Cash Flow Per Share | -0.95 | -1.57 | -3.09 | -5.14 | -20.14 | Upgrade
|
| Cash Interest Paid | - | 0 | 0.57 | 0.88 | 0.95 | Upgrade
|
| Cash Income Tax Paid | 0.11 | -0.59 | -1.65 | 0.04 | 12.22 | Upgrade
|
| Levered Free Cash Flow | -156.64 | -169.03 | -191.36 | -289.31 | -1,086 | Upgrade
|
| Unlevered Free Cash Flow | -141.94 | -161.12 | -187.74 | -288.76 | -1,086 | Upgrade
|
| Change in Working Capital | 20.37 | -2.68 | -57.06 | -110.69 | -38.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.